Fungal infections of the genitourinary system: manifestations, diagnosis, and treatment

Area of Science:

• Mycology
• Infectious Diseases
• Immunology

Background:

• The prevalence of immunocompromised patients is rising, increasing susceptibility to fungal infections.
• Fungal infections constitute 8% of nosocomial infections, posing a significant healthcare challenge.
• Specific populations like premature infants, the elderly, transplant recipients, and HIV patients are at higher risk.

Purpose of the Study:

• To highlight the increasing threat of fungal infections in immunocompromised individuals.
• To identify key patient groups at risk for invasive fungal infections.
• To discuss the role of the genitourinary system in fungal dissemination and the emergence of specific fungal pathogens.

Main Methods:

• Literature review of current epidemiological data on fungal infections in vulnerable populations.
• Analysis of common and emerging fungal pathogens, including Candida, Aspergillus, Cryptococcus, Blastomyces, Coccidioides, and Histoplasma.
• Examination of the genitourinary system as a potential site for fungal infection.

Main Results:

• Fungal infections are a growing concern, particularly in immunocompromised hosts.
• Candida species remain the most common cause, but Aspergillus, Cryptococcus, and environmental fungi are increasingly significant pathogens.
• The genitourinary tract can serve as a reservoir or target for disseminated fungal infections.

Conclusions:

• Immunocompromised patients require vigilant monitoring for fungal infections.
• The spectrum of fungal pathogens is expanding, necessitating broader diagnostic and therapeutic approaches.
• Environmental fungi pose an increasing threat to vulnerable patient populations.